Tandlægeselskabet Colosseum Brøndby ApS: Financial statements 2022
CVR: 37362085
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Tandlægeselskabet Colosseum Brøndby ApS (CVR 37362085) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 28,458,860 and a net result of DKK -1,954,213 compared with DKK -3,550,097 the year before. That is an increase of 17.3% compared with the year before. Equity in the 2022 report amounted to DKK 8,082,109. The solvency ratio was 35.6%. The company had 35 employees in the financial year.
- Gross Profit
- DKK 28,458,860
- Profit/Loss
- DKK -1,954,213
- Equity
- DKK 8,082,109
- Total Assets
- DKK 22,686,113
- Employees
- 35
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 28.5M | -2M | 8.1M | 35 |
| 2021 | - | 24.3M | -3.6M | 10M | 36 |
| 2020 | - | 20.4M | -2.4M | 13.6M | 30 |
| 2019 | - | 21M | -1.3M | 20.9M | 29 |
| 2018 | - | 19.4M | -2.1M | 22.1M | 30 |
Official annual report
Keep an eye on Tandlægeselskabet Colosseum Brøndby ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Tandlægeselskabet Colosseum Brøndby ApS has published its annual report for 2021. Gross profit came to DKK 24,266,022, and the net result was DKK -3,550,097.
As of June 28, 2022, Erik Andersen has joined the board of directors of Tandlægeselskabet Colosseum Brøndby ApS.
As of June 28, 2022, Cathrine Holst Falkenberg has left the board of directors of Tandlægeselskabet Colosseum Brøndby ApS.
As of June 28, 2022, Hanne Bahrt has stepped down as director of Tandlægeselskabet Colosseum Brøndby ApS.
About Tandlægeselskabet Colosseum Brøndby ApS
Tandlægeselskabet Colosseum Brøndby ApS is a Danish company of the type Anpartsselskab based in Brøndby, founded in 2015. The company is registered under the industry Tandlægers aktiviteter. The company was previously named Colosseum Brøndby ApS and Tandlægeselskabet Evident ApS. The management consists of Erik Andersen. The board consists of Pernille Schlütter Beck (chair), Erik Andersen and Mathias Riis Damgaard. The company is owned by Tandlæge Erik Andersen Holding ApS and Evident Holding ApS. The company has 21 employees (2026). In 2025, the company reported a gross profit of DKK 38,824,010 and a net result of DKK 477,969 compared with DKK 1,492,484 the year before. Equity in the 2025 report amounted to DKK 13,099,871.